saniva diagnostics GmbH is a German medical technology company based in Erfurt, founded in January 2019, focusing on diagnostics.

saniva diagnostics specializes in developing a screening instrument for the early detection of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. The company is currently developing the NeuroMex screening instrument for the early detection of neurological diseases. Two clinical studies are currently underway with healthy subjects and patients with prodromal Parkinson's disease and prodromal Alzheimer's disease. In February 2023, NeuroMex was approved by the FDA.

For more information, please visit: www.sanivadiagnostics.com